Forefront Wealth Partners »

Cytomx Therapeutics shares owned by Forefront Wealth Partners

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Forefront Wealth Partners from 13F filings

Historical chart of Forefront Wealth Partners investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Forefront Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Forefront Wealth Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $58k 18k 3.19

More positions owned by Forefront Wealth Partners

Spdr Series Trust Portfolio S&p500 (SPLG)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Ishares Tr Jpmorgan Usd Emg (EMB)
First Tr Exchange-traded No Amer Energy (EMLP)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard Intl Equity Index F Glb Ex Us Etf (VNQI)
Pimco Etf Tr 15+ Yr Us Tips (LTPZ)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Spdr Series Trust Ftse Int Gvt Etf (WIP)
Barclays Bank Djubs Cmdt Etn36 (DJP)
Vanguard World Extended Dur (EDV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Mbs Etf (MBB)

View all positions for Forefront Wealth Partners

Top funds holding Cytomx Therapeutics

VR Adviser
FMR
Tang Capital Management
Perceptive Advisors
Vanguard Group
OrbiMed Advisors
Commodore Capital
Balyasny Asset Management
Baker Bros. Advisors
Point72 Asset Management
ADAR1 Capital Management
Kynam Capital Management
Rtw Investments
Ikarian Capital
Vivo Capital

View all funds holding Cytomx Therapeutics